Involvement of the prostaglandin E receptor EP2 in paeoniflorin-induced human hepatoma cell apoptosis

Anti-Cancer Drugs

Volumn 24, Issue 2, 2013, Pages 140-149

  Hu, Shanshan ^a   Sun, Wuyi ^a   Wei, Wei ^a   Wang, Di ^a   Jin, Juan ^a   Wu, Jingjing ^a   Chen, Jingyu ^a   Wu, Huaxun ^a   Wang, Qingtong ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

apoptosis; butaprost; caspase 3; EP2; hepatocellular carcinoma; paeoniflorin

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; BUTAPROST; CASPASE 3; FLUORESCEIN ISOTHIOCYANATE; LIPOCORTIN 5; PAEONIFLORIN; PROPIDIUM IODIDE; PROSTAGLANDIN E RECEPTOR 2; PROTEIN BAX; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL GROWTH; CELL PROLIFERATION; CELL STIMULATION; CELL STRAIN HEPG2; CELL SURVIVAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; FLOW CYTOMETRY; HEPATOMA CELL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; WESTERN BLOTTING;

ALPROSTADIL; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BENZOATES; BRIDGED COMPOUNDS; CARCINOMA, HEPATOCELLULAR; CASPASE 3; CELL LINE, TUMOR; CELL PROLIFERATION; DINOPROSTONE; GLUCOSIDES; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, PROSTAGLANDIN E, EP2 SUBTYPE;

EID: 84873089929     PISSN: 09594973     EISSN: 14735741     Source Type: Journal    
DOI: 10.1097/CAD.0b013e32835a4dac     Document Type: Article

References (37)

1. Shiota G, Okubo M, Noumi T, Noguchi N, Oyama K, Takano Y, et al. Cyclooxygenase-2 expression in hepatocellular carcinoma. Hepatogastroenterology 1999; 46:407-412
2. Koga H, Sakisaka S, Ohishi M, Kawaguchi T, Taniguchi E, Sasatomi K, et al. Expression of cyclooxygenase-2 in human hepatocellular carcinoma: Relevance to tumor dedifferentiation. Hepatology 1999; 29:688-696
3. Bae SH, Jung ES, Park YM, Kim BS, Kim BK, Kim DG, et al. Expression of cyclooxygenase-2 (COX-2) in hepatocellular carcinoma and growth inhibition of hepatoma cell lines by a COX-2 inhibitor, NS-398. Clin Cancer Res 2001; 7:1410-1418
4. Leng J, Han C, Demetris AJ, Michalopoulos GK, Wu T. Cyclooxygenase-2 promotes hepatocellular carcinoma cell growth through Akt activation: Evidence for Akt inhibition in celecoxib-Induced apoptosis. Hepatology 2003; 38:756-768
5. Cheng AS, Chan HL, To KF, Leung WK, Chan KK, Liew CT, et al. Cyclooxygenase-2 pathway correlates with vascular endothelial growth factor expression and tumor angiogenesis in hepatitis B virus-Associated hepatocellular carcinoma. Int J Oncol 2004; 24:853-860
6. Mayoral R, Fernandez-Martinez A, Bosca L, Martin-Sanz P. Prostaglandin E2 promotes migration and adhesion in hepatocellular carcinoma cells. Carcinogenesis 2005; 26:753-761
7. Takahashi T, Ogawa H, Izumi K, Uehara H. The soluble EP2 receptor FuEP2/Ex2 suppresses endometrial cancer cell growth in an orthotopic xenograft model in nude mice. Cancer Lett 2011; 306:67-75
8. Ansari KM, Sung YM, He G, Fischer SM. Prostaglandin receptor EP2 is responsible for cyclooxygenase-2 induction by prostaglandin E2 in mouse skin. Carcinogenesis 2007; 28:2063-2068
9. Rasmuson A, Kock A, Fuskevag OM, Kruspig B, Simon-Santamaria J, Gogvadze V, et al. Autocrine prostaglandin E2 signaling promotes tumor cell survival and proliferation in childhood neuroblastoma. PLoS One 2012; 7:e29331
10. Kuo KT, Wang HW, Chou TY, Hsu WH, Hsu HS, Lin CH, et al. Prognostic role of PGE2 receptor EP2 in esophageal squamous cell carcinoma. Ann Surg Oncol 2009; 16:352-360
11. Yu L, Wu WK, Li ZJ, Li HT, Wu YC, Cho CH. Prostaglandin E(2) promotes cell proliferation via protein kinase C/extracellular signal regulated kinase pathway-Dependent induction of c-Myc expression in human esophageal squamous cell carcinoma cells. Int J Cancer 2009; 125: 2540-2546
12. Jime'nez P, Piazuelo E, Cebrian C, Ortego J, Strunk M, Garci'a-Gonzalez MA, et al. Prostaglandin EP2 receptor expression is increased in Barrett's oesophagus and oesophageal adenocarcinoma. Aliment Pharmacol Ther 2010; 31:440-451
13. Breinig M, Rieker R, Eiteneuer E, Wertenbruch T, Haugg AM, Helmke BM, et al. Differential expression of E-prostanoid receptors in human hepatocellular carcinoma. Int J Cancer 2008; 122:547-557
14. Hung JY, Yang CJ, Tsai YM, Huang HW, Huang MS. Antiproliferative activity of paeoniflorin is through cell cycle arrest and the Fas/Fas ligand-mediated apoptotic pathway in human non-small cell lung cancer A549 cells. Clin Exp Pharmacol Physiol 2008; 35:141-147
15. Wu H, Li W, Wang T, Shu Y, Liu P. Paeoniflorin suppress NF-kappaB activation through modulation of I kappaB alpha and enhances 5-fluorouracil-Induced apoptosis in human gastric carcinoma cells. Biomed Pharmacother 2008; 62:659-666
16. Zhang L, Zhang S. Modulating Bcl-2 family proteins and caspase-3 in induction of apoptosis by paeoniflorin in human cervical cancer cells. Phytother Res 2011; 25:1551-1557
17. Fang S, Zhu W, Zhang Y, Shu Y, Liu P. Paeoniflorin modulates multidrug resistance of a human gastric cancer cell line via the inhibition of NF-kappaB activation. Mol Med Report 2012; 5:351-356
18. Liu DF,Wei W, Song LH. Protective effect of paeoniflorin on immunological liver injury induced by bacillus Calmette-Guerin plus lipopolysaccharide: Modulation of tumour necrosis factor-Alpha and interleukin-6 MRNA. Clin Exp Pharmacol Physiol 2006; 33:332-339
19. Chu D, Du M, Hu X,Wu Q, Shen J. Paeoniflorin attenuates schistosomiasis japonica-Associated liver fibrosis through inhibiting alternative activation of macrophages. Parasitology 2011; 138:1259-1271
20. Kern MA, Schubert D, Sahi D, Schoneweiss MM, Moll I, Haugg AM, et al. Proapoptotic and antiproliferative potential of selective cyclooxygenase-2 inhibitors in human liver tumor cells. Hepatology 2002; 36:885-894
21. Hu KQ, Yu CH, Mineyama Y, McCracken JD, Hillebrand DJ, Hasan M. Inhibited proliferation of cyclooxygenase-2 expressing human hepatoma cells by NS-398, a selective COX-2 inhibitor. Int J Oncol 2003; 22: 757-763
22. Kern MA, Schoneweiss MM, Sahi D, Bahlo M, Haugg AM, Kasper HU, et al. Cyclooxygenase-2 inhibitors suppress the growth of human hepatocellular carcinoma implants in nude mice. Carcinogenesis 2004; 25: 1193-1199
23. Nagahara T, Okano J, Fujise Y, Abe R, Murawaki Y. Preventive effect of JTE-522, a selective cyclooxygenase-2 inhibitor, on DEN-Induced hepatocarcinogenesis in rats. Biomed Pharmacother 2010; 64: 319-326
24. Fitzgerald GA. Coxibs and cardiovascular disease. N Engl J Med 2004; 351:1709-1711
25. Jones SC. Relative thromboembolic risks associated with COX-2 inhibitors. Ann Pharmacother 2005; 39:1249-1259
26. Liu H, Wei W, Li X. Celecoxib exacerbates hepatic fibrosis and induces hepatocellular necrosis in rats treated with porcine serum. Prostaglandins Other Lipid Mediat 2009; 88:63-67
27. Cusimano A, Fodera D, Lampiasi N, Azzolina A, Notarbartolo M, Giannitrapani L, et al. Prostaglandin E2 receptors and COX enzymes in human hepatocellular carcinoma: Role in the regulation of cell growth. Ann NY Acad Sci 2009; 1155:300-308
28. Castellone MD, Teramoto H, Williams BO, Druey KM, Gutkind JS. Prostaglandin E2 promotes colon cancer cell growth through a Gs-Axinbeta-catenin signaling axis. Science 2005; 310:1504-1510
29. Banu SK, Lee J, Speights VJ, Starzinski-Powitz A, Arosh JA. Selective inhibition of prostaglandin E2 receptors EP2 and EP4 induces apoptosis of human endometriotic cells through suppression of ERK1/2, AKT, NFkappaB, and beta-catenin pathways and activation of intrinsic apoptotic mechanisms. Mol Endocrinol 2009; 23:1291-1305
30. Tessner TG, Muhale F, Riehl TE, Anant S, Stenson WF. Prostaglandin E2 reduces radiation-Induced epithelial apoptosis through a mechanism involving AKT activation and bax translocation. J Clin Invest 2004; 114:1676-1685
31. Chen BC, Liao CC, Hsu MJ, Liao YT, Lin CC, Sheu JR, et al. Peptidoglycaninduced IL-6 production in RAW 264.7 macrophages is mediated by cyclooxygenase-2, PGE2/PGE4 receptors, protein kinase A, I kappa B kinase, and NF-kappa B. J Immunol 2006; 177:681-693
32. Nishikawa T, Nakajima T, Moriguchi M, Jo M, Sekoguchi S, Ishii M, et al A green tea polyphenol, epigalocatechin-3-gallate, induces apoptosis of human hepatocellular carcinoma, possibly through inhibition of Bcl-2 family proteins. J Hepatol 2006; 44:1074-1082
33. Wang P, Zhu F, Lee NH, Konstantopoulos K. Shear-Induced interleukin-6 synthesis in chondrocytes: Roles of E prostanoid (EP) 2 and EP3 in cAMP/protein kinase A- And PI3-K/Akt-Dependent NF-kappaB activation. J Biol Chem 2010; 285:24793-24804
34. Wang P, Zhu F, Konstantopoulos K. Prostaglandin E2 induces interleukin-6 expression in human chondrocytes via cAMP/protein kinase A- And phosphatidylinositol 3-kinase-Dependent NF-kappaB activation. Am J Physiol Cell Physiol 2010; 298:C1445-C1456
35. Lin HI, Lee YJ, Chen BF, Tsai MC, Lu JL, Chou CJ, et al. Involvement of Bcl-2 family, cytochrome C and caspase 3 in induction of apoptosis by beauvericin in human non-small cell lung cancer cells. Cancer Lett 2005; 230: 248-259
36. Wang H, Zhou H,Wang CX, Li YS, Xie HY, Luo JD, et al. Paeoniflorin inhibits growth of human colorectal carcinoma HT 29 cells in vitro and in vivo. Food Chem Toxicol 2012; 50:1560-1567
37. Chang Y, Zhang L, Wang C, Jia XY, Wei W. Paeoniflorin inhibits function of synoviocytes pretreated by rIL-1alpha and regulates EP4 receptor expression. J Ethnopharmacol 2011; 137:1275-1282